164 related articles for article (PubMed ID: 18391203)
21. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
Klein G; Klein E; Kashuba E
Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
Oncogene; 2000 Mar; 19(14):1801-6. PubMed ID: 10777214
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus nuclear antigen-1-dependent and -independent oriP-binding cellular proteins.
Kusano S; Tamada K; Senpuku H; Harada S; Ito S; Yanagi K
Intervirology; 2001; 44(5):283-90. PubMed ID: 11684889
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
25. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.
Swenson JJ; Mauser AE; Kaufmann WK; Kenney SC
J Virol; 1999 Aug; 73(8):6540-50. PubMed ID: 10400750
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
Roth G; Curiel T; Lacy J
Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
28. Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA.
Reischig J; Bartsch D; Polack A; Vonka V; Hirsch I
Virology; 1987 Oct; 160(2):498-501. PubMed ID: 2821690
[TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
[TBL] [Abstract][Full Text] [Related]
30. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
31. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
Wang Y; Finan JE; Middeldorp JM; Hayward SD
Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
[TBL] [Abstract][Full Text] [Related]
32. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
Boreström C; Forsman A; Rüetschi U; Rymo L
J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
[TBL] [Abstract][Full Text] [Related]
33. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
Shukla SK; Jha HC; El-Naccache DW; Robertson ES
Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus nuclear antigen type 1 binding: electron microscopy.
Hirsch I; Reischig J; Benada O; Bartsch D; Brichácek B; Boguszaková L; Vonka V
J Virol Methods; 1988 Dec; 22(2-3):133-42. PubMed ID: 2851598
[TBL] [Abstract][Full Text] [Related]
36. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
Rooney CM; Brimmell M; Buschle M; Allan G; Farrell PJ; Kolman JL
J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality.
Chang YH; Lee CP; Su MT; Wang JT; Chen JY; Lin SF; Tsai CH; Hsieh MJ; Takada K; Chen MR
PLoS One; 2012; 7(6):e39217. PubMed ID: 22768064
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
39. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
40. The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle.
Zacny VL; Wilson J; Pagano JS
J Virol; 1998 Oct; 72(10):8043-51. PubMed ID: 9733844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
